MSB 5.42% $1.46 mesoblast limited

Cell Therapy News/Articles, page-3709

  1. 1,609 Posts.
    lightbulb Created with Sketch. 1691
    Spot on. The depth of analysis from these knuckledraggers is pathetic. The Motley Fool drop in at the end was all I needed to see to categorise this one as a waste of time.
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.